المؤلفون: Solman, I., Singh Mali, R., Scarfo, L., Choi, M., Moreno, C., Grigg, A., Dean, J. P., Szafer‐Glusman, E.

المصدر: HemaSphere; 2022 Supplement 3, Vol. 6, p45-46, 2p

المؤلفون: Singh Mali R; Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA., Zhang Q; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., DeFilippis RA; Division of Hematology and Oncology, University of California at San Francisco, San Francisco, USA., Cavazos A; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Kuruvilla VM; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Raman J; Division of Hematology and Oncology, University of California at San Francisco, San Francisco, USA., Mody V; Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA., Choo EF; Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USA., Dail M; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Shah NP; Helen Diller Comprehensive Cancer Center, University of California at San Francisco, USA., Konopleva M; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Sampath D; Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA., Lasater EA; Department of Translational Oncology, Genentech, Inc., South San Francisco, CA, USA.

المصدر: Haematologica [Haematologica] 2021 Apr 01; Vol. 106 (4), pp. 1034-1046. Date of Electronic Publication: 2021 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Adult ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Cell Line, Tumor ; Humans ; Protein Kinase Inhibitors ; Sulfonamides/pharmacology ; Tumor Microenvironment ; fms-Like Tyrosine Kinase 3/genetics